Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_assertion type Assertion NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_head.
- NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_assertion description "[Mixed-cell tumours, representing majority of uveal melanomas, may be further subclassified according to COX-2 expression, a marker of poor prognosis/in uveal melanoma should be further elucidated/inhibitors may be adjuvant treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_provenance.
- NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_assertion evidence source_evidence_literature NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_provenance.
- NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_assertion SIO_000772 12956275 NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_provenance.
- NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_assertion wasDerivedFrom lhgdn-20090331 NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_provenance.
- NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_assertion wasGeneratedBy ECO_0000203 NP201291.RAheAAY0GKK4iLa36Da3RLqVKxPCreQbOPmgczqc9iCaw130_provenance.